Article
- The EMBO Journal (2002) 21, 1638 - 1649
- doi:10.1093/emboj/21.7.1638
Subject Categories:
Multiple endocytic trafficking pathways of MHC class I molecules induced by a Herpesvirus protein
Robert E. Means1,4, Satoshi Ishido2,4, Xavier Alvarez3 and Jae U. Jung1
- Department of Microbiology and Molecular Genetics, Division of Tumor Virology, Harvard Medical School, One Pine Hill Drive, Southborough, MA 01772, USA
- Department of Microbiology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan
- Department of Pathology, New England Regional Primate Research Center, Harvard Medical School, One Pine Hill Drive, Southborough, MA 01772, USA
- R.E.Means and S.Ishido contributed equally to this work
Correspondence to:
Jae U. Jung, E-mail: jae_jung@hms.harvard.edu
Received 23 August 2001; Accepted 5 February 2002; Revised 28 January 2002
Abstract
The K3 protein of a human tumor-inducing herpesvirus, Kaposi's sarcoma-associated herpesvirus (KSHV), down-regulates major histocompatibility complex (MHC) class I surface expression by increasing the rate of endocytosis. In this report, we demonstrate that the internalization of MHC class I by the K3 protein is the result of multiple, consecutive trafficking pathways that accelerate the endocytosis of class I molecules, redirect them to the trans-Golgi network (TGN), and target MHC class I to the lysosomal compartment. Remarkably, these actions of K3 are functionally and genetically separable; the N-terminal zinc finger motif and the central sorting motif are involved in triggering internalization of MHC class I molecules and redirecting them to the TGN. Subsequently, the C-terminal diacidic cluster region of K3 is engaged in targeting MHC class I molecules to the lysosomal compartment. These results demonstrate a novel trafficking mechanism of MHC class I molecules induced by KSHV K3, which ensures viral escape from host immune effector recognition.
Keywords:
- endocytosis,
- intercellular trafficking,
- KSHV K3,
- MHC class I,
- viral immune evasion



